Investigational Drug Details
Drug ID: | D404 |
Drug Name: | Chlorella Vulgaris |
Synonyms: | -- |
Type: | Supplement |
DrugBank ID: | -- |
DrugBank Description: | -- |
PubChem ID: | -- |
CasNo: | -- |
Repositioning for NAFLD: | No |
SMILES: | -- |
InChiKey: | -- |
Molecular Weight: | -- |
DrugBank Targets: | -- |
DrugBank MoA: | -- |
DrugBank Pharmacology: | -- |
DrugBank Indication: | -- |
Targets: | -- |
Therapeutic Category: | Prebiotics |
Clinical Trial Progress: | Clinical trial on-going (IRCT2014121620345N1) |
Latest Progress: | Under clinical trials |

Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
---|---|---|---|---|---|---|---|
L0649 | IRCT2012110911220N1 | Not applicable | Not Recruiting | No Results Available | 16/11/2012 | 22 February 2018 | Details |
L0657 | IRCT201202233320N7 | Not applicable | Not Recruiting | No Results Available | 04/05/2012 | 22 February 2018 | Details |
L0862 | IRCT2014121620345N1 | Phase 2/Phase 3 | Not Recruiting | No Results Available | 19/10/2015 | 22 February 2018 | Details |
Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
---|
Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
---|
Article ID | PMID | Source | Title | |
---|---|---|---|---|
A02212 | 34459004 | J Food Biochem | Chlorella vulgaris is an effective supplement in counteracting non-alcoholic fatty liver disease-related complications through modulation of dyslipidemia, insulin resistance, and inflammatory pathways. | Details |
A04609 | 33564655 | Clin Nutr Res | Effect of Chlorella vulgaris on Liver Function Biomarkers: a Systematic Review and Meta-Analysis. | Details |
A17922 | 27475283 | Clin Nutr | Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial. | Details |
A21717 | 25097844 | Health Promot Perspect | The Effect of Chlorella vulgaris Supplementation on Liver En-zymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease. | Details |
A24093 | 23234816 | Hepatogastroenterology | Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. | Details |